AOA Dx Welcomes Abigail McElhinny, PhD, as Chief Scientific Officer
AOA Dx is announcing the addition of a Chief Scientific Officer, Dr. Abigail McElhinny. Dr. McElhinny comes from a background in leadership in oncology diagnostics. This experience will be transformative for the AOA Dx team.